CLINICAL TRIALS PROFILE FOR FLUORODOPA F18
✉ Email this page to a colleague
All Clinical Trials for FLUORODOPA F18
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00674440 ↗ | Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism | Completed | University of Pennsylvania | Phase 2 | 2004-12-01 | Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery. |
| NCT00674440 ↗ | Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism | Completed | Children's Hospital of Philadelphia | Phase 2 | 2004-12-01 | Children with congenital hyperinsulinism (CHI) have low blood sugar, and some of these children may require surgery. In this study, researchers affiliated with the University of Pennsylvania will test how well a radioactive drug (called F-DOPA) can detect a form of hyperinsulinism that may be cured by surgery. Eligible participants in this study will have positron emission tomography (PET) scans with F-DOPA prior to surgery. |
| NCT01165632 ↗ | Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma | Active, not recruiting | National Cancer Institute (NCI) | Early Phase 1 | 2010-07-26 | RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scan, may help in guiding surgery and radiation therapy and allow doctors to plan better treatment. PURPOSE: This clinical trial studies fluorine F 18 fluorodopa-labeled PET scan in planning surgery and radiation therapy in treating patients with newly diagnosed high- or low-grade malignant glioma |
| NCT01165632 ↗ | Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma | Active, not recruiting | Mayo Clinic | Early Phase 1 | 2010-07-26 | RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scan, may help in guiding surgery and radiation therapy and allow doctors to plan better treatment. PURPOSE: This clinical trial studies fluorine F 18 fluorodopa-labeled PET scan in planning surgery and radiation therapy in treating patients with newly diagnosed high- or low-grade malignant glioma |
| NCT01991977 ↗ | 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy | Active, not recruiting | National Cancer Institute (NCI) | Phase 2 | 2013-12-01 | This phase II trial studies how well fluorine F 18 fluorodopa (18F-DOPA)-positron emission tomography (PET) works in finding tumors in patients with newly diagnosed gliomas undergoing radiation therapy. Comparing results of diagnostic procedures done before and during radiation therapy may help doctors predict a patient's response to treatment and help plan the best treatment. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FLUORODOPA F18
Condition Name
Clinical Trial Locations for FLUORODOPA F18
Trials by Country
Clinical Trial Progress for FLUORODOPA F18
Clinical Trial Phase
Clinical Trial Sponsors for FLUORODOPA F18
Sponsor Name
